<strong>WHO</strong> <strong>Drug</strong> <strong>Information</strong> <strong>Vol</strong>. <strong>24</strong>, <strong>No</strong>. 4, <strong>2010</strong>Consultation DocumentsThe International PharmacopoeiaCapreomycini sulfasCapreomycin sulfateDraft proposal for The International Pharmacopoeia (August <strong>2010</strong>).Please address any comments to Quality Assurance and Safety:Medicines, World Health Organization, 1211 Geneva 27, Switzerland.Fax +41227914730 or e-mail to mendyc@who.int. A subscribermailing list is now available to speed up consultation. For moreinformation please contact bonnyw@who.int.Component R 1R 2Capreomycin IA OH -LysylCapreomycin IB H -LysylCapreomycin IIA OH HCapreomycin IIB H HCapreomycin IA: C 25H 48N 14O 16S 2; Capreomycin IB: C 25H 48N 14O 15S 2; Capreomycin IIA:C 19H 35N 12O 15S 2; Capreomycin IIB: C 19H 35N 12O 14S 2Relative molecular mass. Capreomycin IA: 864.9; Capreomycin IB: 848.9,Capreomycin IIA: 735.7; Capreomycin IIB: 719.7Chemical name. Capreomycin IA: (3S)-3,6-diamino-N-[[(2S,5S,8Z,11S,15S)-15-amino-11-[(4R)-2-amino-3,4,5,6-tetrahydropyrimidin-4-yl]-8-[(carbamoylamino)312
<strong>WHO</strong> <strong>Drug</strong> <strong>Information</strong> <strong>Vol</strong>. <strong>24</strong>, <strong>No</strong>. 4, <strong>2010</strong>Consultation Documentsmethylidene]-2-(hydroxymethyl)-3,6,9,12,16-pentaoxo-1,4,7,10,13-pentazacyclohexadec-5-yl]methyl]hexanamide;sulfuric acid.Capreomycin IB: (3S)-3,6-diamino-N-[[(2S,5S,8Z,11S,15S)-15-amino-11-[(4R)-2-amino-3,4,5,6-tetrahydropyrimidin-4-yl]-8-[(carbamoylamino)methylidene]-2-methyl-3,6,9,12,16-pentaoxo-1,4,7,10,13-pentazacyclohexadec-5-yl]methyl]hexanamide;sulfuric acid.Capreomycin IIA: [(Z)-[(3S,9S,12S,15S)-15-amino-9-(aminomethyl)-3-[(4R)-2-amino-3,4,5,6-tetrahydropyrimidin-4-yl]-12-(hydroxymethyl)-2,5,8,11,14-pentaoxo-1,4,7,10,13-pentazacyclohexadec-6-ylidene]methyl]urea; sulfuric acid.Capreomycin IIB: [(Z)-[(3S,9S,12S,15S)-15-amino-9-(aminomethyl)-3-[(4R)-2-amino-3,4,5,6-tetrahydropyrimidin-4-yl]-12-methyl-2,5,8,11,14-pentaoxo-1,4,7,10,13-pentazacyclohexadec-6-ylidene]methyl]urea; sulfuric acid.CAS Reg. <strong>No</strong>. 1405-37-4 (capreomycin sulfate).Description. A white or almost white powder.Solubility. Very soluble in water, practically insoluble in ethanol (~750 g/l) TS and inether.Category. Antituberculosis drug.Storage. Capreomycin sulfate should be kept in a tightly closed container or, if sterile,in a hermetically closed container.Labelling. The label states, where applicable:(1) that the substance is free from bacterial endotoxins,(2) that the substance is sterile.REQUIREMENTSDefinition. Capreomycin sulfate is the disulfate salt of capreomycin, a polypeptidemixture produced by the growth of Streptomyces capreolus. It contains not less than93.0% and not more than 102.0% of capreomycin sulfate, calculated with reference tothe dried substance and taking into account the sum of capreomycins sulfate IA, IB,IIA and IIB. The content of capreomycins sulfate IA and IB is not less than 90%.Identity testsEither tests A and E or tests B, C, D and E may be applied.A. Carry out the examination as described under 1.7 Spectrophotometry in the infraredregion. The infrared absorption spectrum is concordant with the spectrum obtainedfrom capreomycin sulfate RS or with the reference spectrum of capreomycin sulfate.B. Carry out the test as described under 1.14.1 Thin-layer chromatography, using silicagel R5 as the coating substance and a mixture of 30 volumes of phenol R, 10 volumes313
- Page 1 and 2: WHO Drug Information Vol. 24, No. 4
- Page 3 and 4: WHO Drug Information Vol. 24, No. 4
- Page 5 and 6: WHO Drug Information Vol. 24, No. 4
- Page 7 and 8: WHO Drug Information Vol. 24, No. 4
- Page 9 and 10: WHO Drug Information Vol. 24, No. 4
- Page 11 and 12: WHO Drug Information Vol. 24, No. 4
- Page 13 and 14: WHO Drug Information Vol. 24, No. 4
- Page 15 and 16: WHO Drug Information Vol. 24, No. 4
- Page 17 and 18: WHO Drug Information Vol. 24, No. 4
- Page 19 and 20: WHO Drug Information Vol. 24, No. 4
- Page 21: WHO Drug Information Vol. 24, No. 4
- Page 25 and 26: WHO Drug Information Vol. 24, No. 4
- Page 27 and 28: WHO Drug Information Vol. 24, No. 4
- Page 29 and 30: WHO Drug Information Vol. 24, No. 4
- Page 31 and 32: WHO Drug Information Vol. 24, No. 4
- Page 33 and 34: WHO Drug Information Vol. 24, No. 4
- Page 35 and 36: WHO Drug Information Vol. 24, No. 4
- Page 37 and 38: WHO Drug Information Vol. 24, No. 4
- Page 39 and 40: WHO Drug Information Vol. 24, No. 4
- Page 41 and 42: WHO Drug Information Vol. 24, No. 4
- Page 43 and 44: WHO Drug Information Vol. 24, No. 4
- Page 45 and 46: WHO Drug Information Vol. 24, No. 4
- Page 47 and 48: WHO Drug Information Vol. 24, No. 4
- Page 49 and 50: WHO Drug Information Vol. 24, No. 4
- Page 51 and 52: WHO Drug Information Vol. 24, No. 4
- Page 53 and 54: WHO Drug Information Vol. 24, No. 4
- Page 55 and 56: WHO Drug Information Vol. 24, No. 4
- Page 57 and 58: WHO Drug Information Vol. 24, No. 4
- Page 59 and 60: WHO Drug Information Vol. 24, No. 4
- Page 61 and 62: WHO Drug Information, Vol. 24, No.
- Page 63 and 64: WHO Drug Information, Vol. 24, No.
- Page 65 and 66: WHO Drug Information, Vol. 24, No.
- Page 67 and 68: WHO Drug Information, Vol. 24, No.
- Page 69 and 70: WHO Drug Information, Vol. 24, No.
- Page 71 and 72: WHO Drug Information, Vol. 24, No.
- Page 73 and 74:
WHO Drug Information, Vol. 24, No.
- Page 75 and 76:
WHO Drug Information, Vol. 24, No.
- Page 77 and 78:
WHO Drug Information, Vol. 24, No.
- Page 79 and 80:
WHO Drug Information, Vol. 24, No.
- Page 81 and 82:
WHO Drug Information, Vol. 24, No.
- Page 83 and 84:
WHO Drug Information, Vol. 24, No.
- Page 85 and 86:
WHO Drug Information, Vol. 24, No.
- Page 87 and 88:
WHO Drug Information, Vol. 24, No.
- Page 89 and 90:
WHO Drug Information, Vol. 24, No.
- Page 91 and 92:
WHO Drug Information, Vol. 24, No.
- Page 93 and 94:
WHO Drug Information, Vol. 24, No.
- Page 95 and 96:
WHO Drug Information, Vol. 24, No.
- Page 97 and 98:
WHO Drug Information, Vol. 24, No.
- Page 99 and 100:
WHO Drug Information, Vol. 24, No.
- Page 101 and 102:
WHO Drug Information, Vol. 24, No.
- Page 103 and 104:
WHO Drug Information, Vol. 24, No.
- Page 105 and 106:
WHO Drug Information, Vol. 24, No.
- Page 107 and 108:
WHO Drug Information, Vol. 24, No.
- Page 109 and 110:
WHO Drug Information, Vol. 24, No.
- Page 111 and 112:
WHO Drug Information, Vol. 24, No.
- Page 113 and 114:
WHO Drug Information, Vol. 24, No.
- Page 115 and 116:
WHO Drug Information, Vol. 24, No.
- Page 117 and 118:
WHO Drug Information, Vol. 24, No.
- Page 119 and 120:
WHO Drug Information, Vol. 24, No.
- Page 121 and 122:
WHO Drug Information, Vol. 24, No.
- Page 123 and 124:
WHO Drug Information, Vol. 24, No.
- Page 125 and 126:
WHO Drug Information, Vol. 24, No.
- Page 127 and 128:
WHO Drug Information, Vol. 24, No.